All In Biotech

Drug Trial Radar · NCT05905172

Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis

A Randomized, Double-blind, Placebo-controlled, Multicenter, Entecavir-based, Phase IIIb Clinical Trial of Hydronidone Capsule in the Treatment of Liver Fibrosis Associated With Chronic Hepatitis B

Last checked: Nov 19, 2026Latest source record: Jun 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 248 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

248

Planned (sponsor's estimate)

Start

Aug 12, 2023

Primary completion

Jun 20, 2028

Study completion Oct 20, 2028

Sponsor

Sponsor type
Industry
First posted
Jun 15, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a Phase IIIb extension trial following the "A Randomized, Double-blind, Placebo-controlled, Multicenter, Entecavir-based, Phase III Clinical Trial of Hydronidone Capsule in the Treatment of Liver Fibrosis Associated with Chronic Hepatitis B". The main objective of this study is to evaluate the effectiveness and the safety of hydronidone capsules for long-term treatment of patients with chronic viral hepatitis B liver fibrosis.

Conditions

  • Liver Fibrosis

Interventions

  • Hydronidone capsulesDrug

    After randomization, the experimental group received hydronidone capsules three times a day, 3 capsules each time, for 5 years.

  • The placebo capsulesDrug

    After randomization, The control group received three placebo capsules three times a day. 3 capsules each time, for 5 years.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cumulative incidence of clinical endpoint events (defined as the occurrence of any clinical endpoint event).Time frame: 5years

Locations

23 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing youan hospital, the capital of the capital

    Beijing, China · Recruiting

  • Tsinghua Changgeng Hospital, Beijing

    Beijing, China · Recruiting

  • The First Affiliated Hospital of Bengbu Medical University

    Bengbu, China · Recruiting

  • The Second Xiangya Hospital, Central South University

    Changsha, China · Recruiting

  • Xiangya Hospital, Central South University

    Changsha, China · Recruiting

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, China · Recruiting

  • Three Gorges Hospital affiliated to Chongqing University

    Chongqing, China · Recruiting

  • Guizhou Provincial People's Hospital

    Guizhou, China · Recruiting

  • Hangzhou Xixi Hospital (Hangzhou Sixth People's Hospital)

    Hangzhou, China · Recruiting

  • Henan Provincial People's Hospital

    Henan, China · Recruiting

  • Affiliated Hospital of Traditional Chinese Medicine of Southwest Medical University

    Luzhou, China · Recruiting

  • Nanchang Ninth Hospital (Nanchang Central Hospital)

    Nanchang, China · Recruiting

  • The First Affiliated Hospital of Nanchang University

    Nanchang, China · Recruiting

  • The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

    Nanjing, China · Recruiting

  • Ningbo Huamei Hospital, University of Chinese Academy of Sciences

    Ningbo, China · Recruiting

  • Huashan Hospital affiliated to Fudan University

    Shanghai, China · Recruiting

  • Shenzhen Third People's Hospital

    Shenzhen, China · Recruiting

  • The First Affiliated Hospital of Xinxiang Medical College

    Xinxiang, China · Recruiting

  • Yanbian University Affiliated Hospital

    Yanbian, China · Recruiting

  • Zhenjiang Third People's Hospita

    Zhenjiang, China · Recruiting

  • Affiliated Hospital of Zunyi Medical University

    Zunyi, China · Recruiting

  • Beijing Ditan Hospital Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

  • Shanghai General Hospital,Shanghai Jiao Tong University

    Shanghai, Shanghai Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.